{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T16:02:26Z","timestamp":1779811346050,"version":"3.53.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Henan Provincial Science and Technology Research and Development Project","award":["252102311226"],"award-info":[{"award-number":["252102311226"]}]},{"name":"Henan Provincial Natural Science Foundation Project","award":["242300420068"],"award-info":[{"award-number":["242300420068"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-51184-9","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T13:49:21Z","timestamp":1779803361000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nitric oxide dual-enhanced nanosystem boosts ferroptosis-chemotherapy synergy for tumor therapy"],"prefix":"10.1038","volume":"16","author":[{"given":"Xiaoyu","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjin","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songchao","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobao","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanchun","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"key":"51184_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"51184_CR2","first-page":"128","volume":"16","author":"L Zhang","year":"2023","unstructured":"Zhang, L., Wang, M. & Chen, Y. Apoptosis resistance in solid tumors: Mechanisms and clinical implications. J. Hematol. Oncol. 16(1), 128 (2023).","journal-title":"J. Hematol. Oncol."},{"issue":"4","key":"51184_CR3","first-page":"789","volume":"30","author":"Y Liu","year":"2024","unstructured":"Liu, Y., Zhao, J. & Huang, L. Bcl-2 expression predicts chemotherapy response and prognosis in advanced colorectal cancer. Clin. Cancer Res. 30(4), 789\u2013798 (2024).","journal-title":"Clin. Cancer Res."},{"key":"51184_CR4","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","volume":"18","author":"X Chen","year":"2021","unstructured":"Chen, X., Kang, R., Kroemer, G. & Tang, D. Broadening horizons: The role of ferroptosis in cancer. Nat. Rev. Clin. Oncol. 18, 280\u2013296 (2021).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"51184_CR5","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41568-019-0149-1","volume":"19","author":"JP Friedmann Angeli","year":"2019","unstructured":"Friedmann Angeli, J. P., Krysko, D. V. & Conrad, M. Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion. Nat. Rev. Cancer 19, 405\u2013414 (2019).","journal-title":"Nat. Rev. Cancer"},{"key":"51184_CR6","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13045-019-0720-y","volume":"12","author":"Y Mou","year":"2019","unstructured":"Mou, Y. et al. Ferroptosis, a new form of cell death: Opportunities and challenges in cancer. J. Hematol. Oncol. 12, 34 (2019).","journal-title":"J. Hematol. Oncol."},{"key":"51184_CR7","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1021\/acs.biomac.8b00012","volume":"19","author":"B Du","year":"2018","unstructured":"Du, B. et al. A self-targeting, dual ROS\/pH-responsive apoferritin nanocage for spatiotemporally controlled drug delivery to breast cancer. Biomacromol 19, 1026\u20131036 (2018).","journal-title":"Biomacromol"},{"key":"51184_CR8","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/s41589-019-0462-8","volume":"16","author":"AA Kapralov","year":"2020","unstructured":"Kapralov, A. A. et al. Redox lipid reprogramming commands susceptibility of macrophages and microglia to ferroptotic death. Nat. Chem. Biol. 16, 278\u2013290 (2020).","journal-title":"Nat. Chem. Biol."},{"key":"51184_CR9","doi-asserted-by":"publisher","first-page":"10071","DOI":"10.1021\/acs.chemmater.9b03042","volume":"31","author":"Y Guo","year":"2019","unstructured":"Guo, Y. et al. Metal\u2013phenolic network-based nanocomplexes that evoke ferroptosis by apoptosis: Promoted nuclear drug influx and reversed drug resistance of cancer. Chem. Mater. 31, 10071\u201310084 (2019).","journal-title":"Chem. Mater."},{"key":"51184_CR10","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2174\/1566523219666190628152137","volume":"19","author":"X Xia","year":"2019","unstructured":"Xia, X., Fan, X., Zhao, M. & Zhu, P. The relationship between ferroptosis and tumors: A novel landscape for therapeutic approach. Curr. Gene Ther. 19, 117\u2013124 (2019).","journal-title":"Curr. Gene Ther."},{"key":"51184_CR11","doi-asserted-by":"publisher","first-page":"4900","DOI":"10.1111\/jcmm.14511","volume":"23","author":"T Xu","year":"2019","unstructured":"Xu, T. et al. Molecular mechanisms of ferroptosis and its role in cancer therapy. J. Cell. Mol. Med. 23, 4900\u20134912 (2019).","journal-title":"J. Cell. Mol. Med."},{"key":"51184_CR12","doi-asserted-by":"publisher","first-page":"29655","DOI":"10.1021\/acsami.9b10954","volume":"11","author":"Y An","year":"2019","unstructured":"An, Y. et al. Boosting the ferroptotic antitumor efficacy via site-specific amplification of tailored lipid peroxidation. ACS Appl. Mater. Interfaces 11, 29655\u201329666 (2019).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"51184_CR13","doi-asserted-by":"publisher","first-page":"114006","DOI":"10.1016\/j.bcp.2020.114006","volume":"176","author":"K Kashfi","year":"2020","unstructured":"Kashfi, K. Nitric oxide in cancer and beyond preface. Biochem. Pharmacol. 176, 114006 (2020).","journal-title":"Biochem. Pharmacol."},{"key":"51184_CR14","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/nrcardio.2017.224","volume":"15","author":"C Farah","year":"2018","unstructured":"Farah, C., Michel, L. Y. M. & Balligand, J. L. Nitric oxide signalling in cardiovascular health and disease. Nat. Rev. Cardiol. 15, 292\u2013316 (2018).","journal-title":"Nat. Rev. Cardiol."},{"key":"51184_CR15","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3390\/cancers12092594","volume":"12","author":"M Krzystek-Korpacka","year":"2020","unstructured":"Krzystek-Korpacka, M. et al. L-arginine\/nitric oxide pathway is altered in colorectal cancer and can be modulated by novel derivatives from oxicam class of non-steroidal anti-inflammatory drugs. Cancers 12, 143\u2013182 (2020).","journal-title":"Cancers"},{"key":"51184_CR16","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jmmm.2018.02.010","volume":"456","author":"AJ Bruno","year":"2018","unstructured":"Bruno, A. J., Correa, J. R., Pel\u00e1ez-Abell\u00e1n, E. & Urones-Garrote, E. A novel method for the functionalization of aminoacids l-glycine, l-glutamic acid and l-arginine on maghemite\/magnetite nanoparticles. J. Magn. Magn. Mater. 456, 87\u201391 (2018).","journal-title":"J. Magn. Magn. Mater."},{"key":"51184_CR17","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.niox.2019.09.005","volume":"93","author":"A Kamm","year":"2019","unstructured":"Kamm, A. et al. Nitric oxide and its derivatives in the cancer battlefield. Nitric Oxide-Biol. Ch. 93, 102\u2013114 (2019).","journal-title":"Nitric Oxide-Biol. Ch."},{"key":"51184_CR18","first-page":"1231","volume":"8","author":"E Hays","year":"2019","unstructured":"Hays, E. & Bonavida, B. Nitric oxide-mediated enhancement and reversal of resistance of anticancer therapies. Antioxidants (Basel) 8, 1231\u20131498 (2019).","journal-title":"Antioxidants (Basel)"},{"key":"51184_CR19","first-page":"122345","volume":"302","author":"M Zhang","year":"2024","unstructured":"Zhang, M. & Liu, Y. NO-mediated GPX4 inhibition and GSH depletion: A dual targeting strategy for ferroptosis amplification. Biomaterials 302, 122345\u2013122358 (2024).","journal-title":"Biomaterials"},{"key":"51184_CR20","first-page":"215987","volume":"556","author":"L Wang","year":"2023","unstructured":"Wang, L. & Chen, H. Concentration-dependent NO regulation in tumor ferroptosis and apoptosis. Cancer Lett. 556, 215987\u2013215999 (2023).","journal-title":"Cancer Lett."},{"key":"51184_CR21","doi-asserted-by":"crossref","first-page":"114865","DOI":"10.1016\/j.addr.2023.114725","volume":"195","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y., Li, J. & Wang, H. The EPR effect revisited: Mechanisms, limitations, and optimization strategies for nanodrug delivery to tumors. Adv. Drug Deliv. Rev. 195, 114865\u2013114882 (2023).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"51184_CR22","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.cclet.2019.03.025","volume":"30","author":"S Wang","year":"2019","unstructured":"Wang, S., Liao, H., Li, F. & Ling, D. A mini-review and perspective on ferroptosis-inducing strategies in cancer therapy. Chin. Chem. Lett. 30, 847\u2013852 (2019).","journal-title":"Chin. Chem. Lett."},{"key":"51184_CR23","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/adma.201904197","volume":"31","author":"C Liang","year":"2019","unstructured":"Liang, C., Zhang, X., Yang, M. & Dong, X. Recent progress in ferroptosis inducers for cancer therapy. Adv. Mater. 31, 190\u2013197 (2019).","journal-title":"Adv. Mater."},{"key":"51184_CR24","doi-asserted-by":"publisher","first-page":"13135","DOI":"10.1021\/acs.langmuir.9b02300","volume":"35","author":"F Wu","year":"2019","unstructured":"Wu, F. et al. Hyaluronic acid-modified porous carbon-coated Fe3O4 nanoparticles for magnetic resonance imaging-guided photothermal\/chemotherapy of tumors. Langmuir 35, 13135\u201313144 (2019).","journal-title":"Langmuir"},{"key":"51184_CR25","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.matchemphys.2020.123082","volume":"251","author":"AI Pav\u00f3n-Hern\u00e1ndez","year":"2020","unstructured":"Pav\u00f3n-Hern\u00e1ndez, A. I. et al. Magnetic nanocomposite with fluorescence enhancement effect based on amino acid coated-Fe3O4 functionalized with quantum dots. Mater. Chem. Phys. 251, 143\u2013182 (2020).","journal-title":"Mater. Chem. Phys."},{"key":"51184_CR26","first-page":"114987","volume":"198","author":"P Huang","year":"2025","unstructured":"Huang, P. & Lin, J. Stimulus-responsive iron-based nanocarriers for tumor-specific ferroptosis therapy. Adv. Drug Deliv. Rev. 198, 114987\u2013115002 (2025).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"51184_CR27","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1021\/acs.nanolett.9b01093","volume":"19","author":"YH Hu","year":"2019","unstructured":"Hu, Y. H. et al. Nanoscale coordination polymers for synergistic NO and chemodynamic therapy of liver cancer. Nano Lett. 19, 2731\u20132738 (2019).","journal-title":"Nano Lett."},{"key":"51184_CR28","first-page":"4120","volume":"20","author":"C Shi","year":"2026","unstructured":"Shi, C., Wang, Y. & Li, Z. Gas signaling molecules amplify ferroptosis of porous nanocarriers for enhanced anti-tumor therapy. ACS Nano 20, 4120\u20134135 (2026).","journal-title":"ACS Nano"},{"key":"51184_CR29","first-page":"45","volume":"201","author":"J Chen","year":"2025","unstructured":"Chen, J., Zheng, H. & Yang, W. Crosstalk between NO signaling and ferroptosis: Implications for cancer therapy. Free Radic. Biol. Med. 201, 45\u201358 (2025).","journal-title":"Free Radic. Biol. Med."},{"issue":"16","key":"51184_CR30","first-page":"1671235","volume":"45","author":"M Rodriguez","year":"2026","unstructured":"Rodriguez, M., Gonzalez, A. & Martinez, P. Dissecting the opposing regulatory functions of endogenous nitric oxide production in colorectal cancer initiation and ferroptosis execution. Oncogene 45(16), 1671235 (2026).","journal-title":"Oncogene"},{"key":"51184_CR31","first-page":"146532","volume":"478","author":"S Paiman","year":"2024","unstructured":"Paiman, S., Gupta, A. & Singh, R. Recent progress and challenges of MOF-based nanocomposites in bioimaging, biosensing and biocarriers for drug delivery. Chem. Eng. J. 478, 146532 (2024).","journal-title":"Chem. Eng. J."},{"key":"51184_CR32","first-page":"122389","volume":"302","author":"H Guo","year":"2023","unstructured":"Guo, H., Liu, Z. & Zhang, Q. Biocompatibility issues of MOF-based nanomedicines: Current status and future perspectives. Biomaterials 302, 122389 (2023).","journal-title":"Biomaterials"},{"key":"51184_CR33","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.carbpol.2019.04.024","volume":"216","author":"C Yan","year":"2019","unstructured":"Yan, C., Liang, N., Li, Q., Yan, P. & Sun, S. Biotin and arginine modified hydroxypropyl-beta-cyclodextrin nanoparticles as novel drug delivery systems for paclitaxel. Carbohydr. Polym. 216, 129\u2013139 (2019).","journal-title":"Carbohydr. Polym."},{"key":"51184_CR34","doi-asserted-by":"publisher","first-page":"11000","DOI":"10.1021\/acsnano.8b05042","volume":"12","author":"L Feng","year":"2018","unstructured":"Feng, L. et al. Magnetic targeting, tumor microenvironment-responsive intelligent nanocatalysts for enhanced tumor ablation. ACS Nano 12, 11000\u201311012 (2018).","journal-title":"ACS Nano"},{"key":"51184_CR35","doi-asserted-by":"publisher","first-page":"12380","DOI":"10.1021\/acsnano.8b06399","volume":"12","author":"S Wang","year":"2018","unstructured":"Wang, S. et al. Arginine-rich manganese silicate nanobubbles as a ferroptosis-inducing agent for tumor-targeted theranostics. ACS Nano 12, 12380\u201312392 (2018).","journal-title":"ACS Nano"},{"key":"51184_CR36","doi-asserted-by":"publisher","first-page":"9226","DOI":"10.1021\/acsami.9b20846","volume":"12","author":"S Wang","year":"2020","unstructured":"Wang, S., Jin, D., Bian, Y., Wang, R. & Zhang, L. Electrostatically fabricated three-dimensional magnetite and MXene hierarchical architecture for advanced lithium-ion capacitors. ACS Appl. Mater. Interfaces 12, 9226\u20139235 (2020).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"51184_CR37","doi-asserted-by":"publisher","first-page":"33484","DOI":"10.1021\/acsami.6b11839","volume":"8","author":"H Zhang","year":"2016","unstructured":"Zhang, H. et al. An intelligent and tumor-responsive Fe(2+) donor and Fe(2+)-dependent drugs cotransport system. ACS Appl. Mater. Interfaces. 8, 33484\u201333498 (2016).","journal-title":"ACS Appl. Mater. Interfaces."},{"key":"51184_CR38","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s11581-019-02844-6","volume":"25","author":"S Guo","year":"2019","unstructured":"Guo, S. et al. Synthesis and characterization of L-arginine\/Fe3O4 adsorbent for the removal of methyl orange from aqueous solutions. Ionics 25, 1323\u20131330 (2019).","journal-title":"Ionics"},{"key":"51184_CR39","doi-asserted-by":"publisher","first-page":"7046","DOI":"10.1002\/anie.202015082","volume":"60","author":"X Fang","year":"2021","unstructured":"Fang, X. et al. Photogenerated holes mediated nitric oxide production for hypoxic tumor treatment. Angew. Chem. Int. Ed. 60, 7046\u20137050 (2021).","journal-title":"Angew. Chem. Int. Ed."},{"key":"51184_CR40","first-page":"2308976","volume":"34","author":"Y Liu","year":"2024","unstructured":"Liu, Y. et al. pH\/redox dual-responsive arginine-functionalized nanoplatform for targeted NO delivery and enhanced ferroptosis in cancer therapy. Adv. Funct. Mater. 34, 2308976 (2024).","journal-title":"Adv. Funct. Mater."},{"key":"51184_CR41","first-page":"5624","volume":"17","author":"J Chen","year":"2023","unstructured":"Chen, J. et al. H2O2-triggered NO release from metal-organic frameworks boosts immunogenic cell death and checkpoint blockade therapy. ACS Nano 17, 5624\u20135637 (2023).","journal-title":"ACS Nano"},{"key":"51184_CR42","first-page":"11201","volume":"23","author":"L Zhang","year":"2023","unstructured":"Zhang, L. et al. Acid-enhanced H2O2 activation in arginine-modified Fe3O4 nanocomposites for TME-specific NO generation. Nano Lett. 23, 11201\u201311210 (2023).","journal-title":"Nano Lett."},{"key":"51184_CR43","first-page":"4562","volume":"19","author":"Q Lin","year":"2025","unstructured":"Lin, Q. et al. Nanozyme as tumor energy homeostasis disruptor to augment cascade catalytic therapy. ACS Nano 19, 4562\u20134575 (2025).","journal-title":"ACS Nano"},{"key":"51184_CR44","first-page":"64610","volume":"16","author":"Y Zhang","year":"2025","unstructured":"Zhang, Y. et al. Steering H2O2 lysis pathway for ros generation in prussian blue nanozymes via alkali cation doping. Nat. Commun. 16, 64610 (2025).","journal-title":"Nat. Commun."},{"key":"51184_CR45","doi-asserted-by":"publisher","first-page":"202401434","DOI":"10.1002\/anie.202401434","volume":"63","author":"Z Liu","year":"2024","unstructured":"Liu, Z. et al. Efficient homolytic cleavage of H2O2 on hydroxyl-enriched spinel CuFe2O4 with dual Lewis acid sites. Angew. Chem. Int. Ed. 63, 202401434 (2024).","journal-title":"Angew. Chem. Int. Ed."},{"key":"51184_CR46","doi-asserted-by":"crossref","first-page":"15678","DOI":"10.3390\/ijms232415678","volume":"23","author":"A Cordeiro da Silva","year":"2022","unstructured":"Cordeiro da Silva, A. et al. Flow cytometry detection of anthracycline-treated breast cancer cells: An optimized protocol. Int. J. Mol. Sci. 23, 15678 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"51184_CR47","first-page":"123","volume":"2235","author":"Z Darzynkiewicz","year":"2021","unstructured":"Darzynkiewicz, Z. et al. Methods to detect apoptosis by flow cytometry. Methods Mol. Biol. 2235, 123\u2013140 (2021).","journal-title":"Methods Mol. Biol."},{"key":"51184_CR48","first-page":"55","volume":"349","author":"D Wlodkowic","year":"2022","unstructured":"Wlodkowic, D. et al. Annexin V for flow cytometric detection of phosphatidylserine expression on apoptotic cells. J. Immunol. Methods 349, 55\u201362 (2022).","journal-title":"J. Immunol. Methods"},{"key":"51184_CR49","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1158\/1538-7445.AM2023-2527","volume":"83","author":"CM O\u2019Connor","year":"2023","unstructured":"O\u2019Connor, C. M. et al. Investigation of doxorubicin interference in flow cytometry measurements of apoptosis and necrosis. Cancer Res. 83, 2527 (2023).","journal-title":"Cancer Res."},{"key":"51184_CR50","first-page":"8901","volume":"17","author":"X Liu","year":"2023","unstructured":"Liu, X. et al. pH\/GSH-responsive doxorubicin release from Fe3O4-based nanoparticles for tumor-specific therapy. ACS Nano 17, 8901\u20138915 (2023).","journal-title":"ACS Nano"},{"key":"51184_CR51","first-page":"123105","volume":"320","author":"W Tang","year":"2025","unstructured":"Tang, W. et al. In vivo anti-tumor efficacy of Arginine-Doxorubicin-Fe3O4 nanoparticles in B16 melanoma-bearing mice. Biomaterials 320, 123105 (2025).","journal-title":"Biomaterials"},{"key":"51184_CR52","doi-asserted-by":"publisher","first-page":"122890","DOI":"10.1016\/j.biomaterials.2024.122890","volume":"312","author":"Q Wang","year":"2025","unstructured":"Wang, Q. et al. Arginine-functionalized nanoparticles as endogenous NO donors: In vitro quantification and antitumor efficacy. Biomaterials 312, 122890 (2025).","journal-title":"Biomaterials"},{"key":"51184_CR53","first-page":"5678","volume":"18","author":"L Zhang","year":"2024","unstructured":"Zhang, L. et al. Arginine-modified mesoporous Fe3O4 nanoparticles via hydrothermal synthesis for targeted drug delivery. ACS Nano 18, 5678\u20135692 (2024).","journal-title":"ACS Nano"},{"key":"51184_CR54","first-page":"2407891","volume":"21","author":"M Li","year":"2025","unstructured":"Li, M., Wang, H. & Chen, Y. Ultrasonic-assisted loading of doxorubicin onto arginine-functionalized Fe3O4 nanoparticles for enhanced solubility. Small 21, 2407891 (2025).","journal-title":"Small"},{"key":"51184_CR55","first-page":"3210","volume":"24","author":"J Zhao","year":"2024","unstructured":"Zhao, J. et al. Multiscale Characterization of mesoporous Fe3O4 nanocarriers for antitumor drug delivery. Nano Lett. 24, 3210\u20133221 (2024).","journal-title":"Nano Lett."},{"key":"51184_CR56","first-page":"8901","volume":"17","author":"X Liu","year":"2023","unstructured":"Liu, X., Zhang, Y. & Li, Z. pH\/GSH-responsive doxorubicin release from Fe3O4-based nanoparticles for tumor-specific therapy. ACS Nano 17, 8901\u20138915 (2023).","journal-title":"ACS Nano"},{"key":"51184_CR57","doi-asserted-by":"crossref","first-page":"2306543","DOI":"10.1002\/smll.202306543","volume":"20","author":"L Chen","year":"2024","unstructured":"Chen, L., Huang, S. & Wang, J. Peroxidase-like activity of mesoporous Fe3O4 nanoparticles: pH dependence and mechanism insight. Small 20, 2306543 (2024).","journal-title":"Small"},{"key":"51184_CR58","first-page":"456","volume":"352","author":"Y Hu","year":"2023","unstructured":"Hu, Y. et al. Cytotoxicity evaluation of magnetic nanoparticles via SRB assay: Importance of cell line authentication. J. Control. Release 352, 456\u2013468 (2023).","journal-title":"J. Control. Release"},{"key":"51184_CR59","first-page":"7890","volume":"19","author":"R Xiao","year":"2025","unstructured":"Xiao, R., Zhang, M. & Li, Q. Tumor homing of Arginine-functionalized Fe3O4 nanoparticles: Visualization via fluorescence microscopy. ACS Nano 19, 7890\u20137905 (2025).","journal-title":"ACS Nano"},{"key":"51184_CR60","first-page":"121765","volume":"298","author":"H Yang","year":"2024","unstructured":"Yang, H. et al. Intracellular ROS generation induced by Fe3O4-based nanocarriers: Detection via DCFH-DA and flow cytometry. Biomaterials 298, 121765 (2024).","journal-title":"Biomaterials"},{"key":"51184_CR61","first-page":"4120","volume":"20","author":"C Shi","year":"2026","unstructured":"Shi, C., Wang, Y. & Li, Z. Gas signaling molecules amplify ferroptosis of porous nanocarriers for enhanced anti-tumor therapy. ACS Nano 20, 4120\u20134135 (2026).","journal-title":"ACS Nano"},{"key":"51184_CR62","first-page":"9876","volume":"24","author":"X Zhou","year":"2024","unstructured":"Zhou, X. et al. In vivo biodistribution of IR783-labeled Fe3O4 nanoparticles monitored via NIR imaging. Nano Lett. 24, 9876\u20139888 (2024).","journal-title":"Nano Lett."},{"key":"51184_CR63","first-page":"095002","volume":"28","author":"L Sun","year":"2023","unstructured":"Sun, L. & Wang, Z. Statistical analysis in biomedical research: Application of one-way ANOVA for nanodrug efficacy data. J. Biomed. Opt. 28, 095002 (2023).","journal-title":"J. Biomed. Opt."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51184-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51184-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51184-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T15:03:55Z","timestamp":1779807835000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51184-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["51184"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-51184-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"assertion":[{"value":"12 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16300"}}